Palbociclib Viatris 125 mg
As listed in the register: Palbociclib Viatris 125 mg, filmomhulde tabletten
125 mg · filmomhulde tablet
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Palbociclib
- Made by
- Viatris Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Ibrance). It describes the substance, not this exact product.
Palbociclib is an inhibitor of cyclin-dependent kinases (CDK) 4 and 6.
Cyclin D1 and CDK4/6 are downstream of signaling pathways which lead to cellular proliferation.
Palbociclib was extensively metabolized with unchanged drug accounting for 2.3% and 6.9% of radioactivity in feces and urine, respectively.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-07-06
Safety of the active substance
From the US prescribing label for the same active substance (Ibrance). It describes the substance, not this exact product.
The most common adverse reactions (≥10%) of any grade reported in patients in the IBRANCE plus letrozole arm by descending frequency were neutropenia, infections, leukopenia, fatigue, nausea, alopecia, stomatitis, diarrhea, anemia, rash, asthenia, thrombocytopenia, vomiting, decreased appetite, dry skin, pyrexia, and dysgeusia.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States2 matching products
European UnionNo exact match for this strength and form
Spain1 matching products
FranceNo exact match for this strength and form
Canada4 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | Viatris Limited |
|---|---|
| Active substance | Palbociclib |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 125 mg |
| Form | filmomhulde tablet |
| Classification | L01EF01 · Cancer treatments and immune-system medicines |
| Route | oraal gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Palbociclib Viatris 125 mg, filmomhulde tabletten |
| RVG | EU/1/26/2039 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.